Loading…
Lobbying Spend
—
Filings
27
Firms Hired
1
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
Consolidated Appropriations Act, 2023
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
PATIENT Act of 2023
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
PATIENT Act of 2023
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Consolidated Appropriations Act, 2023
2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and the 340B Drug Pricing Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
Consolidated Appropriations Act, 2023
2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and the 340B Drug Pricing Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and the 340B Drug Pricing Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
340B Transparency Act
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program; NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3290
340B Transparency Act
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3290
PATIENT Act of 2023
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
PATIENT Act of 2023
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program; NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program; NCI designation.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
340B Transparency Act
2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3290
340B Transparency Act
2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3290
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3561
Lower Costs, More Transparency Act
2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023, H.R.5378 - Lower Costs, More Transparency Act); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
340B Transparency Act
2023 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023); and H.R. 3290 - 340B Drug Discount Program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3290
Source: Senate LDA